Yongmei H. Liu
Beijing, 100730, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Potential Mechanisms and Hypotheses for Pathogenic Microorganisms Triggering Kawasaki Disease.
Journal: Clinical reviews in allergy & immunology
Published: October 11, 2025
The treatment of myocardial ischemia-reperfusion injury: potential roles of natural drug modulating CaMKII.
Journal: Frontiers in pharmacology
Published: October 03, 2025
Distinct features of humoral and cellular immunity against Omicron breakthrough infection among chronic liver disease patients: An experience from a follow-up cohort.
Journal: Human vaccines & immunotherapeutics
Published: August 15, 2025
Autoantibody profiling using microarray identifies biomarkers associated with chemoimmunotherapy efficacy and immune-related adverse events in lung cancer patients.
Journal: Clinical and experimental medicine
Published: May 14, 2025
Mitochondrial mass and mitochondrial membrane potential of peripheral lymphocytes: promising biomarkers of systemic lupus erythematosus.
Journal: Frontiers in molecular biosciences
Published: March 01, 2025
Autoantibody reactome analysis reveals diagnostic biomarkers and molecular classification for relapsing polychondritis.
Journal: Annals of the rheumatic diseases
Published: December 23, 2024
Mass Cytometry Analysis of High-Dimensional Single-Cell Immune Profiles in ZF2001-Vaccinated Patients Infected with SARS-CoV-2.
Journal: Infection and drug resistance
Published: December 12, 2024
Proteome-Wide Analysis of Antibody Responses in Asymptomatic Omicron BA.2-Infected Individuals at the Amino Acid Resolution.
Journal: Journal of proteome research
Published: December 11, 2024
Maintenance of Long-Term Effective Humoral Immune Response in Patients with COVID-19 with Homologous or Heterologous Booster Vaccines: A Retrospective Study.
Journal: Viral immunology
Published: December 05, 2024
Elucidating SARS-CoV-2 neurotropism: a comprehensive Mendelian randomization study on cerebrospinal fluid biomarkers and their relevance to COVID-19 neurological manifestations.
Journal: Virology journal
Published: December 03, 2024
Identifying Neurological Autoantibodies in COVID-19: mGluR2 as a Marker of Immune Dysregulation During the Omicron Outbreak in China.
Journal: Journal of medical virology
Published: November 08, 2024
Last Updated: 09/26/2026